Dear CAMRT members,
This is a follow up to the February 16, 2018 message on the the current global supply situation of medical isotopes.
The AIPES’ Emergency Response Team has advised of the following:
- The NTP reactor has received conditional approval to restart production.
- Three production runs will occur this week with the product anticipated to start reaching the supply chain by the week’s end.
- NTP officials are working to resume full production as soon as possible.
- It is anticipated that the resumption of NTP Mo-99 production will improve the international supply situation and alleviate the tightness in the supply chain which has been experienced during the NTP outage.
The Government of Canada is monitoring the situation closely and is committed to keeping you informed as we receive updated information.
As we mentioned in the last update, we are interested to hear if you are experiencing any disruption to your own local supply of medical isotopes. Please send these updates, or any other feedback to Christopher Topham, Director of Advocacy and Communications at firstname.lastname@example.org.